Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Other Populations

Reports

Displaying 21 - 30 of 950. 10 per page. Page 3.

Advanced Search
Research Brief

Racial, Ethnic, and Socioeconomic Differences in COVID-19 Diagnosis and Mortality Among Nursing Home Residents

Nursing homes have been disproportionately impacted by COVID-19. The purpose of this study was to examine whether there were racial, ethnic, and socioeconomic differences in COVID-19 infection and mortality rates at both the nursing home resident and nursing home facility levels. The study includes national data on COVID-19 outcomes for nursing home residents through the end of June 2021.
ASPE Issue Brief

Medicare Drug Price Negotiation Program: Medicare Prices Negotiated for 2026 Compared to List and U.S. Market Prices

The Inflation Reduction Act (IRA) makes improvements to Medicare to increase accessibility and affordability of prescription drugs for Medicare enrollees, reduce the rate of growth in Medicare drug spending, and improve the financial sustainability of the Medicare program.
ASPE Issue Brief

Barriers and Opportunities for Improving Interstate Licensure Portability for Behavioral Health Practitioners: Technical Expert Panel Findings Issue Brief

In October 2022, ASPE convened a virtual technical expert panel (TEP) to discuss policy options that encourage interstate licensure among behavioral health providers.
ASPE Issue Brief

Building Successful Data Linking Teams for Child Welfare and Medicaid Agencies: Lessons Learned from the Child Welfare and Health Infrastructure for Linking and Data Analysis of Resources, Effectiveness, and Needs (CHILDREN) Initiative

Linking data across public systems is beneficial for a multitude of reasons including care coordination, improving research on populations engaged with multiple public services, and improving program integrity.
ASPE Issue Brief, Database, Dataset, Report

Developing a Database of SUD Treatment Needs

A 2020 study examined the feasibility of using substance use disorder (SUD) patient intake assessment data as source of information for treatment planning.
ASPE Issue Brief

Integrating Services to Strengthen Children, Youth, and Families and Prevent Involvement in the Child Welfare System

The Office of the Assistant Secretary for Planning and Evaluation in the U.S. Department of Health and Human Services has been working with researchers, human services agency leaders, and persons with lived experience to visualize, describe, and document models of primary prevention within human services.
Fact Sheet

Exploration of Child Welfare Systems’ Experiences with Custody Relinquishment

This one-pager describes the research questions and objectives of a project exploring the use of custody relinquishment, or when children enter foster care primarily to obtain behavioral health or disability services.
Fact Sheet

Improving Services for Children and Families through Linked Child Welfare and Medicaid Data

This two-pager describes several child welfare and Medicaid data linking projects and lessons learned from those projects. For example, the brief highlights key lessons such as the value in providing states with support in navigating data governance and in strengthening and harmonizing data infrastructure on child welfare service.
Environmental Scan

Impact of COVID-19 on Clinical Trials Costs to Patients

This environmental scan, conducted by Mathematica and funded by ASPE, examines the types of direct and direct costs to patients associated with clinical trial participation. It also explores the effect of COVID-19 on costs to patients, including cost implications of clinical trial innovations widely implemented during COVID-19 and other efforts to increase diversity of clinical trials.